The Global Digestive Enzymes Market will reach USD 1.29 Billion by 2028, at a CAGR of 6.1% over the forecast period. The increasing demand for digestive enzymes among the urban population will drive the digestive enzymes market over the forecast period. The growth in average life expectancy due to the continuous innovation in healthcare by scientists has led to the demand for innovative health solutions like digestive enzymes.

The elderly population is more at risk to develop GI tract problems. So, a rising elderly population across the globe can increase the demand for digestive enzymes and prompt consumers to use prebiotic and probiotic products. This, in turn, can boost the growth of the global market. An increase in life expectancy is a factor that is influencing the growth of the digestive enzymes market.

The population demographic around the world is changing rapidly as the elderly population has been growing steadily. According to the World Health Organization, the number of individuals above 65 years of age will touch 1.5 billion by 2050. With growing age, the ability to create enzymes declines. Therefore, the increasing elderly population will lead to a rise in gastrointestinal issues all around the world, thereby stimulating the digestive enzymes market. Hence, by 2050, the digestive enzymes market will be one of the largest markets in the healthcare sector.

Digestive Enzymes Market, By Enzyme Type:

Based on type, the market segmentation includes carbohydrates, protease, lipase, and others. Lipase is an enzyme involved in the hydrolysis of fats or lipids. It acts as a catalyst and breaks down oils and solid fats into compounds. Its function is to assist digestion and transport and treat of dietary lipids. Lipase has uses in dairy, bakery, and oil & fat businesses. It is one of the fastest-growing enzymes and is widely grown because of the evolution of the food & beverage industry. The growth of the lipase segment is due to its applications in the dairy industry.

Digestive Enzymes Market, By Origin:

Based on origin, the market segmentation comprises fungi, animal, plant, and microbial. The plant segment dominates the market with the largest share. It is because the plant-based enzymes are more effective than the animal-based ones. The plant-based enzymes have a broader pH range of activity. Plant-based enzymes such as papain from papaya and bromelain from pineapple have proteolytic activity. In the future, the microbial segment is expected to record the highest growth. The increasing use of Plant-based enzymes due to its availability has led to its increased demand.

Digestive Enzymes Market, By Application:

Based on the application, the market segmentation includes indigestion, chronic pancreatitis, Irritable Bowel Syndrome, and others. Increasing incidence of pancreatic and gastrointestinal diseases and surgeries is another factor that is projected to fuel the demand for digestive enzymes across the globe. Chronic pancreatitis leads to the failure of the pancreas to secrete the enzymes necessary for digestion.

The deficiency of pancreatic enzymes is very common among individuals with pancreatic cancer. When the pancreas does not create enough enzymes to break down food, pancreatic enzyme products are required. Doctors occasionally recommend digestive enzymes, including pancreatic enzymes, to individuals who have disorders that cause absorption issues. These products help enhance digestion and absorption of food. This has led to the growth of the chronic pancreatitis segment.

Digestive Enzymes Market, By Region:

North America held the largest market share in the global digestive enzymes market. Hectic schedules and unhealthy eating behaviors, mainly in the U.S., have boosted the market growth. The market in North America is expected to retain its dominant position in the market. Europe is another important market that has evolved due to the presence of a well-established healthcare infrastructure and high disposable income of consumers.

In terms of growth rate, however, Asia Pacific is likely to outpace all other regions, powered by nations like India and China. These densely populated and fast-expanding large economies have a sizeable chunk of population suffering from digestive disorders because of a fast-paced lifestyle, and untenable eating habits. This, in turn, has augmented the demand for digestive enzymes.

Key Digestive Enzymes Market Developments

• May 22, 2020 - Sanofi, the company of leading Irritable Bowel Syndrome brand Buscopan and constipation relief range Dulcolax, has entered the digestive health space with the introduction of a new food supplement, Buscobiota. Formulated to support digestive health, Buscobiota is a one-a-day pill that comprises five scientifically considered strains of live cultures, along with calcium, which assists the normal function of digestive enzymes.
• July 14, 2020 - FRISKA, a health and wellness brand, has launched ten new dietary supplements focused on refining gut health, a key element to overall health and well-being. Based on the understanding that 70-80% of the immune cells in the body exist in the gut, FRISKA proprietary combination of digestive enzymes and a clinically proven probiotic anchor each of the exceptional formula.
• February 2019, Codexis, Inc., a U.S.-based protein engineering company, entered into a multi-year, exclusive supply agreement with KYORIN Pharmaceuticals Co., Ltd. for the supply of proprietary enzyme. The enzyme developed of vibegron is an active component in Beova Tablets, used for treating overactive bladder.
• March 2019 - A manufacturing biotech company, AB Enzymes, launched ROHALASE SEPARATION, a grain-processing enzyme. It is a food-grade enzyme made from the wheat-starch-gluten separation process.
• February 15, 2018 - The Digestive Center, a reliable name in Digestive health and cutting-edge research, launched ACTZYM. It is a digestive enzyme formula to help with the breakdown of food and absorption of vital minerals and vitamins.
• In 2017, Abbot Nutrition, a subsidiary of Abbot Laboratories, announced the acquisition of St. Jude Medical, Inc., establishing the company as a leader in the medical industry. The transaction provides Abbott with expanded opportunities for future growth and ongoing effort to develop nutritional pharmaceuticals and digestive supplements for the stomach, GI tract, gall bladder, and spleen.

Some Key Findings of the Global Digestive Enzymes Market Report Include:

• The study includes the global Digestive Enzymes Market analysis, trends, and forecasts, along with a country-specific analysis.
• An in-depth analysis of the global Digestive Enzymes Market includes an analysis by enzyme type, by origin, by application, and by Regions, along with the analysis of trend-based insights and factors.
• Product offerings details on competitive benchmarking and development approaches adopted by the industry players, along with their investments in the last five years in the global Digestive Enzymes Market.
• The market research includes a study of the provinces, limitations, drivers, prospects, guidelines, challenges, and procedures that are impelling the global Digestive Enzymes Market.
• Some major industry players functional in the global Digestive Enzymes Market include National Enzyme Company, Garden of Life Inc., Food State Inc., Metagenics Inc., Twinlab Corporation, Country Life LLC, Rainbow Light Nutritional Systems Inc., Biotics Research Corporation, Matsun Nutrition, and Abbott Nutrition.

Market Segmentation:

By Enzyme Type:

• Carbohydrates
• Protease
• Lipase
• Others

By Origin:

• Fungi
• Animal
• Plant
• Microbial

By Application:

• Indigestion
• Chronic Pancreatitis
• Irritable Bowel Syndrome
• Others

By Region:

• North America
• Western Europe
• Eastern Europe
• Asia Pacific
• Middle East
• Rest of the world